GLOBUS MEDICAL INC acquires NuVasive, Inc.

GLOBUS MEDICAL INC acquired NuVasive, Inc. for Stock-for-stock merger at a fixed exchange ratio of 0.75 Globus Medical share per NuVasive share; pro forma ownership ~72% Globus Medical / ~28% NuVasive shareholders, a transaction completed in September 2023, structured as all stock. The deal was a merger.

NuVasive, Inc. operates in Spine & musculoskeletal — spine implants and enabling technology, is based in San Diego, California, USA. NuVasive, Inc. is a San Diego-based global medical technology company focused on spine surgery, known for its lateral access procedures and the Pulse enabling-technology platform spanning surgical planning, navigation, imaging and intraoperative neuromonitoring.

Combining to create a leading global musculoskeletal company with complementary global scale, expanded commercial reach, comprehensive portfolios in spine and orthopedics, and increased operational capabilities.

Complementary spine portfolio and the Pulse enabling-technology platform, roughly doubling Globus Medical's scale and adding lateral-access expertise and broader commercial reach. Combined under Globus Medical (NYSE: GMED), with David Paul as Executive Chairman and Dan Scavilla as CEO Dan Scavilla, President and CEO, Globus Medical (Sept 1, 2023 completion release): "We're thrilled to begin our journey together to create a leading global musculoskeletal company. With a relentless focus on changing patient lives, we're combining our differentiated portfolios and talented teams to reach more customers as we advance spine and orthopedic care globally."